Income Taxes - Schedule of Provision for Income Taxes with Income Tax at Federal Statutory Rate (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income (loss) before income taxes		$ 5,068,413	$ 2,186,138	$ (774,751)
Expected income tax provision (benefit) based on U.S. federal statutory tax rate		1,064,367	459,089	(162,698)
State and local income taxes, net of federal benefit		126,932	77,979	(24,808)
Tax benefit (deficiency) from stock-based compensation		(5,282)	5,869	4,927
Federal tax credit for increasing research activities	[1]	(151,913)	0	0
Other, net		(13,300)	(8,733)	(1,085)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount		0	(14,474)	14,474
Provision (benefit) for income taxes		$ 1,020,804	$ 519,730	$ (169,190)
Federal statutory income tax rate		21.00%	21.00%	21.00%
Effective tax rate		20.10%	23.80%	21.80%

[1] In 2022, the Company commenced a study to determine the amount of its qualified research activities performed during the tax years of 2018 to 2022 that qualify for a research and development income tax credit under the Internal Revenue Code. A $152 million decrease in the Company’s income tax provision was recognized in 2022 to account for eligible tax credits identified as a result of the study.